Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
$5.08
-1.9%
$0.00
$4.83
$7.76
$238.35M0.8104,342 shs123,770 shs
SAA
ProShares Ultra SmallCap600
$24.35
-1.1%
$23.60
$16.47
$26.00
$32.63M2.359,485 shs260 shs
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
$131.36
+0.3%
$128.23
$109.87
$131.67
$20.78B0.68366,128 shs337,828 shs
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
$0.00
$0.16
$0.62
N/AN/A1,714 shs51,582 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
0.00%0.00%0.00%0.00%-4.16%
SAA
ProShares Ultra SmallCap600
+2.24%+6.03%+0.45%+4.82%+27.84%
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
+0.82%+2.26%+0.82%+6.19%+7.17%
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
1.0633 of 5 stars
0.04.00.01.22.03.30.6
SAA
ProShares Ultra SmallCap600
N/AN/AN/AN/AN/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
N/AN/AN/AN/A
SAA
ProShares Ultra SmallCap600
0.00
N/A$25.173.36% Upside
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
0.00
N/A$138.635.53% Upside
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
$1.09B0.22$1.32 per share3.86$4.31 per share1.18
SAA
ProShares Ultra SmallCap600
N/AN/AN/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/AN/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
$20.59M$0.2124.19N/A1.23%12.94%6.81%N/A
SAA
ProShares Ultra SmallCap600
N/AN/A0.00N/AN/AN/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/A19.72N/AN/AN/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
N/AN/AN/AN/AN/A
SAA
ProShares Ultra SmallCap600
$0.100.41%N/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
$3.202.44%N/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
N/A
1.50
1.50
SAA
ProShares Ultra SmallCap600
N/AN/AN/A
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/AN/AN/A
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Radiant Logistics, Inc. stock logo
RLGT
Radiant Logistics
87246.92 million35.43 millionNot Optionable
SAA
ProShares Ultra SmallCap600
N/A1.34 millionN/ANot Optionable
SPDR S&P Dividend ETF stock logo
SDY
SPDR S&P Dividend ETF
N/A158.20 millionN/ANot Optionable
Vodis Pharmaceuticals Inc stock logo
VP
Vodis Pharmaceuticals
N/AN/AN/ANot Optionable

RLGT, SDY, XPS, VP, and SAA Headlines

SourceHeadline
Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonaldScorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald
tmcnet.com - May 7 at 9:13 AM
VP Harris announces more than $100 mln to support auto workersVP Harris announces more than $100 mln to support auto workers
reuters.com - May 6 at 8:34 AM
COVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™COVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™
tmcnet.com - March 27 at 1:27 PM
States drug pricing boards off to a slow startStates' drug pricing boards off to a slow start
msn.com - March 22 at 8:16 AM
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
mmm-online.com - March 20 at 6:45 PM
Verrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference CallVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Call
msn.com - February 25 at 2:28 PM
Abivax appoints Ana Sharma as Vice President, Global Head of QualityAbivax appoints Ana Sharma as Vice President, Global Head of Quality
markets.businessinsider.com - February 7 at 8:56 AM
Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s HealthMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health
markets.businessinsider.com - January 24 at 1:10 PM
Senior Vice PresidentSenior Vice President
govtech.com - December 20 at 9:06 AM
Dr Reddys becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023Dr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023
msn.com - December 14 at 3:30 PM
Biden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patents
msn.com - December 7 at 3:45 PM
The White House is threatening the patents of high-priced drugs developed with taxpayer dollarsThe White House is threatening the patents of high-priced drugs developed with taxpayer dollars
abcnews.go.com - December 7 at 9:38 AM
Amneal Pharma in pact with Strides to launch generic VascepaAmneal Pharma in pact with Strides to launch generic Vascepa
msn.com - December 1 at 3:25 PM
Anavex Life Sciences Appoints Senior VP of Regulatory AffairsAnavex Life Sciences Appoints Senior VP of Regulatory Affairs
markets.businessinsider.com - November 6 at 8:21 AM
Xpengs vice president suspended amid corruption investigation in supply chain managementXpeng's vice president suspended amid corruption investigation in supply chain management
foxnews.com - October 14 at 11:38 PM
Lexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart DrugLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drug
marketwatch.com - October 9 at 6:33 PM
Strengthening of vertical integration: Exyte completes acquisition of pure media specialist IntegaStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Intega
markets.businessinsider.com - October 4 at 6:44 AM
Vice PresidentVice President
newsweek.com - September 19 at 1:02 PM
Republican voters want Donald Trump. And his vice president? How about more Trump?Republican voters want Donald Trump. And his vice president? How about more Trump?
usatoday.com - August 28 at 4:23 AM
Teva Pharmaceuticals to pay $225M fine to settle price-fixing chargesTeva Pharmaceuticals to pay $225M fine to settle price-fixing charges
news.yahoo.com - August 22 at 4:12 AM
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call TranscriptVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
msn.com - August 1 at 10:03 PM
See which pharma brands are the strongest and fastest-growing in 2023See which pharma brands are the strongest and fastest-growing in 2023
mmm-online.com - July 12 at 1:54 PM
Senior Vice President, Corporate Development and Global StrategySenior Vice President, Corporate Development and Global Strategy
webmd.com - June 9 at 11:51 PM
What has Kamala Harris done as vice president?What has Kamala Harris done as vice president?
news.yahoo.com - May 29 at 8:36 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Radiant Logistics logo

Radiant Logistics

NYSEAMERICAN:RLGT
Radiant Logistics, Inc., a third-party logistics company, provides technology-enabled global transportation and value-added logistics solutions primarily in the United States and Canada. The company offers domestic, international air, and ocean freight forwarding services; and freight brokerage services, including truckload and intermodal services. It also provides logistics and supply chain services, including MM&D, CHB, and GTM services, as well as heavyweight and small package air services. In addition, the company offers air network services. It serves aviation and automotive, electronics and high tech, furniture and home furnishings, hospitality and gaming, humanitarian/NGO, industrial farming, and manufacturing and consumer goods; medical, healthcare, and pharmaceuticals; military and government; oil, gas, and energy; residential and white glove; retail, textile, apparel, and accessories; and trade shows, events, and advertising, as well as sporting goods industries. Radiant Logistics, Inc. was incorporated in 2001 and is headquartered in Renton, Washington.

ProShares Ultra SmallCap600

NYSEARCA:SAA
ProShares Ultra SmallCap600 (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the S&P SmallCap 600 Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.
SPDR S&P Dividend ETF logo

SPDR S&P Dividend ETF

NYSEARCA:SDY
The SPDR S&P Dividend ETF seeks to closely match the returns and characteristics of the S&P High Yield Dividend Aristocrats Index (the Index). The Index is designed to measure the performance of the 60 highest dividend yielding S&P Composite 1500 Index constituents that have followed a managed-dividends policy of consistently increasing dividends every year for at least 25 consecutive years. The Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including money market funds advised by the Adviser). SSgA Funds Management, Inc. is the investment adviser to the Fund.
Vodis Pharmaceuticals logo

Vodis Pharmaceuticals

CNSX:VP
Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.